Search Results 8731-8740 of 33664 for oral

  1. Minimally invasive surgery - Doctors & Departments - Mayo Clinic

    ... Oral and throat cancer, Adenocarcinoma, Tongue base cancer, Oropharyngeal cancer. Show more areas of focus for Eric J. Moore, M.D.. Adyr A ...

  2. A Study to Evaluate the Effectiveness and Safety of DA-1229 (Evogliptin) in Delaying Progression of Mild or Moderate Calcific Aortic Stenosis (EVOID-AS trial) - Mayo Clinic

    * Acceptable methods of contraception include abstinence, female subject/partner's use of hormonal contraceptive (oral, implanted, or injected) in ...

  3. Publications - Michael R. Henry, M.D. - Mayo Clinic

    Oral Progestogens Versus Levonorgestrel-Releasing Intrauterine System for Treatment of Endometrial Intraepithelial Neoplasia . J Womens Health (Larchmt) ...

  4. Q&A: Caring for patients with genetic mutations predisposed to ovarian cancer - Mayo Clinic

    There are other things shown to decrease the chance of developing ovarian cancer, such as use of combined oral contraceptive pills, tubal ligation ...

  5. Thyroid cancer - Doctors and departments - Mayo Clinic

    ... Oral and throat cancer, Adenocarcinoma, Laryngeal cancer, Carotid body tumor, Tongue base cancer, Mouth tumor, Salivary gland cancer, Parotid cancer ...

  6. Phase III Study to Evaluate the Efficacy and Safety of the INTERCEPT Blood System for Red Blood Cells in Patients Undergoing Complex Cardiac Surgery Procedures - Mayo Clinic

    implants, injectables, combined oral contraceptives, some intrauterine devices (IUDs), sexual abstinence or vasectomized partner 6. Signed and dated ...

  7. Clinical trials - Oncology (Medical)

    Patients randomized to GDC-0199+R will be given GDC-0199 daily (oral, target dose 400 mg) and will receive 6 cycles of rituximab infused intravenously (IV) ...

  8. Surgery - Doctors - Mayo Clinic

    ... Oral and throat cancer, Adenocarcinoma, Tongue base cancer, Oropharyngeal cancer. Show more areas of focus for Eric J. Moore, M.D. ...

  9. Publications - Julia A. Files, M.D. - Mayo Clinic

    You can't fool mother nature: new directions in oral contraception. J Womens Health (Larchmt). 2012 Mar; 21(3):366-7. Epub 2012 Feb 10. View PubMed; Hayes SN ...

  10. A Study of APG-2575 Alone or in Combination with Other Therapeutic Agents to Treat Relapsed and/or Refractory Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) - Mayo Clinic

    Hormonal contraceptives (oral, parenteral, vaginal ring or transdermal) for at least 3 months prior to study drug administration. If hormonal contraceptives ...